Introduction Governmental drug policy is a significant issue, which has been the center of public controversy in the recent years. There is still no applicable solution to this problem in the global society of the 21 st century. Among the most alarming issues are overdoses, death, and degenerative illnesses such as Hepatitis C. The success of the policies introduced in developed countries vary noticeably, which demonstrates the absence of a perfect solution for everyone. It is possible to assume that the choice of the governmental strategy depends on the historical past of the country, behavior patterns of its citizens, and specificities of the law system. This academic work examines two countries in terms of their drug policy framework – Sweden and the Netherlands. The approaches used in these states are contradicting; therefore, it is vital to investigate and compare them in order to evaluate their strengths and weaknesses. The purpose of this paper is to describe and compare the crucial aspects of the drug policies in the chosen countries. Global Overview of the Drug Strategies In order to prevent the negative consequences of illegal use of drugs, national and local authorities control their distribution. Rogeberg et al. claim that the most noticeable problems nowadays are the poor quality of drugs and the absence of the regulation system. Thus, it is necessary to organize the process of monitoring and control. Consequently, it would be favorable for evaluating the drug quality distributed among the healthcare organizations and regulating the amount of sold items. In addition, it is necessary to point out that there is no option to minimize the production of drugs because there are patients for whom using these medicaments is the only way to stay alive. In the majority of developed European countries, drug use is strictly prohibited. Nevertheless, as stated by the Global Commission on Drug Policy (GCDP), criminalization and severe penalties are not the most effective way to stop the functioning of the illegal market. The specialists maintain that people’s safety and comfort are one of the most critical values that should not be underestimated. In this case, it is possible to suggest that hard drugs cannot be absolutely restricted, as humans with serious diseases need them to feel better. Annan et al., GCDP commissioners, also introduce an example of the US strategy where decriminalization of some drugs leads to the improvement of public health in general. The central conclusion of the specialists is that the legalization of several types of medicaments may be beneficial for society. Despite that, the representatives of the authorities cannot introduce the management strategy that would function in an efficient way. The legal system needs to implement efficient frameworks, which would consider that humans who use drugs are already addicted and cannot control their doses in a rational way. It is evident there are various steps that are already implemented in many countries, including both decriminalization as well as restriction of drug use and distribution. The world experience is an illustration of the fact that both strategies may become successful in t